Bactericidal Activity of Serum by Brucella Abortus RB51 Outer Membrane Protein’s Combined by Brucella Abortus S99 Lipopolysaccharide Induction

  • Behnam Hajizadeh Sisakht Department of Bacteriology, Faculty of Veterinary, Islamic Azad University, Science & Research Campus, Tehran, Iran
  • Mansoor Khaledi Department of Microbiology and Immunology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
  • Hamed Afkhami Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran
  • Saber Rouhi Resident of Large Animal Internal Medicine, Department of Clinical Sciences, School of Veterinary Medicine, Shiraz University, Iran
  • Saeed Sepehrnia Department of Immunology, Faculty of Medicine, Shahed University, Tehran, Iran
  • Vahideh Fanaee Department of Microbiology and Immunology, School of Medicine, Shahrekord University of Medical Sciences,Shahrekord, Iran
  • Hannaneh Karimi Department of Microbiology, Rasht Islamic Azad University, Guilan, Iran
  • Yalda Malekzadegan Department of Microbiology, Saveh University of Medical Sciences, Saveh, Iran
  • Javad Fathi Department of Medical Bacteriology and Virology, Faculty of Medicine, Shiraz University of Medical Sciences,Shiraz, Iran
  • Mahdi S. Sadati Department of Microbiology, Faculty of Biological Sciences, Islamic Azad University Tehran-North Branch, Tehran,Iran
Keywords: Agar, Brucellosis, Cellular, Combined, Humoral, Immunity, Immunity, Lipopolysaccharides, Vaccines

Abstract

Background: Brucellosis vaccines are designed to induce cellular immunity. An effective brucellosis vaccine could induce both cellular and humoral immunity. Serum Bactericidal Assay (SBA) is an important method for determining vaccine humoral immunity. This study is the first to observe humoral immunity in brucellosis by SBA.

Methods: Extracted Brucella abortus (B. abortus) Lipopolysaccharide (LPS) and Outer Membrane Proteins (OMPs) were injected into rabbits. Group 1 was injected with 25 µg of LPS, Group 2 was injected with 50 µg of OMPs, and Group 3 was injected with 1 ml of combined vaccine, 3 times every 2 weeks. The groups were challenged with B. abortus 544 in the second injection. Sera were separated 2 weeks after the last injection. SBA was performed, and each well was streak-cultured into a plate of Brucella agar. A colony count was done for each plate.

Results: Results have shown, the third injection of the combined vaccine had the highest titer of , and the efficacy of the vaccine was 87.71%.

Conclusion: As a conclusion, the results of this study showed that LPS and OMP's from B. abortus can provide acceptable immunity.

Published
2024-06-16
Section
Articles